US Patent

US12304813 — Sodium thiosulfate-containing pharmaceutical compositions

Formulation · Assigned to Hope Medical Enterprises Inc · Expires 2030-02-10 · 4y remaining

Vulnerability score 61/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical compositions containing sodium thiosulfate and methods for producing and using it.

USPTO Abstract

Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.

Drugs covered by this patent

Patent Metadata

Patent number
US12304813
Jurisdiction
US
Classification
Formulation
Expires
2030-02-10
Drug substance claim
No
Drug product claim
Yes
Assignee
Hope Medical Enterprises Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.